BioWorld MedTech

April 23, 2012

FDA clears Abbott's iFS laser for cataract surgery

Abbott (Abbott Park, Illinois) reported FDA clearance to use its iFS advanced femtosecond laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery. Read More

Report from Israel: Tortuous path seen from research to clinic for personalized medicine

Report from Europe: PIP implant failures significantly higher than previously thought

Washington roundup: FDA reposts warning letter months after initial posting

Agreements/contracts: HearPo reveals plan to offer discounted hearing care services

MDD's Fun Facts

Court report: Zeltiq successful in false claims claims case of its cooling system

Restructuring roundup: MAI in plan to realign 3 strategic business units

Patent watch: CLS receives patent for translation risk management

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...